CKD-EPI 2021 Creatinine-Cystatin C
Chronic Kidney Disease Epidemiology Collaboration
Creatinine–cystatin C equation for adults, without a race coefficient
- Biomarkers
- Creatinine + cystatin C
- Validated for
- 18+ years
- Inputs
- Age, Sex, Creatinine, Cystatin C
- Reports
- mL/min/1.73 m²
- Published
- 2021
The eGFR guide explains which equation the calculator suggests and indexed and absolute GFR.
Formula
As text: eGFR = 135 × min(SCr/κ,1)^α × max(SCr/κ,1)^(-0.544) × min(Scys/0.8,1)^(-0.323) × max(Scys/0.8,1)^(-0.778) × 0.9961^age × 0.963 [if female]
Constants
| Symbol | Meaning | Value |
|---|---|---|
135 | Base coefficient | |
| Sex-dependent creatinine coefficient | Female: 0.7mg/dL Male: 0.9mg/dL | |
| Creatinine exponent when SCr/κ < 1 | Female: −0.219 Male: −0.144 | |
−0.544 | Creatinine exponent when SCr/κ ≥ 1 | |
0.8 | Cystatin C reference value | mg/L |
−0.323 | Cystatin C exponent when SCys/0.8 < 1 | |
−0.778 | Cystatin C exponent when SCys/0.8 ≥ 1 | |
0.9961 | Age decay factor (base for age exponent) | per year |
Sex factor | Sex-dependent multiplier | Female: 0.963 Male: 1.000 |
| Serum creatinine (input) | mg/dL | |
SCys | Serum cystatin C (input) | mg/L |
Age | Patient age (input) | years |
How it was developed
Refitted without a race term on the CKD-EPI 2012 development data, which had both creatinine and cystatin C: 13 studies with 5,352 adults aged 18 or older, with GFR measured by urinary or plasma clearance of exogenous filtration markers. External validation used 12 studies (4,050 participants).
Clinical notes
- Developed with creatinine and cystatin C assays traceable to reference materials
- KDIGO 2024 specifies creatinine from the same sample as cystatin C
Limitations
- Studied in ambulatory adults without serious coexisting conditions, not acute care
- Development data excluded kidney transplant recipients
- May err with very low muscle mass, high inflammation, catabolic states or steroids
References
- Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. doi:10.1016/j.kint.2023.10.018